Language:
  
[Sign in] [Register]   

EIAab logo

Index > Protein center > KDR(Gene name) > Human
  • Add your favorite
  • KDR (Gene name),
  • Vascular endothelial growth factor receptor 2 (Protein name ),  VGFR2_HUMAN from NCBI database.
  • top
  • Come back to page head.
  • |
  • General Annotation
  • |
  • Antigen Annotation
  • |
  • 3D
  • |
  • Predicted Eptitope
  • |
  • Vaild Sequence
  • |
  • Related Databases
  • |
  • Feedback
  • Gene name:
    KDR(FLK1;VEGFR2);
    Protein name:
    Vascular endothelial growth factor receptor 2(VEGFR-2);
    Alternative:
    Kinase insert domain receptor(KDR);Fetal liver kinase 1(FLK-1);Protein-tyrosine kinase receptor flk-1;
    CD:
    CD309;
    Organism:
    Human (Homo sapiens). 
    General Annotation
    Sub Unit:
    Interacts with MYOF (By similarity). Interacts with SHB; upon VEGF activation. Interacts with HIV-1 Tat.
    Function:
    Receptor for VEGF or VEGFC. Has a tyrosine-protein kinase activity. The VEGF-kinase ligand/receptor signaling system plays a key role in vascular development and regulation of vascular permeability. In case of HIV-1 infection, the interaction with extracellular viral Tat protein seems to enhance angiogenesis in Kaposi's sarcoma lesions.
    Subcellular Location:
    Membrane Single-pass type I membrane protein
    Protein Attributes:
    Sequence length:
    1356
    Sequence:
    50:
    MQSKVLLAVA | LWLCVETRAA | SVGLPSVSLD | LPRLSIQKDI | LTIKANTTLQ | 
    100:
    ITCRGQRDLD | WLWPNNQSGS | EQRVEVTECS | DGLFCKTLTI | PKVIGNDTGA | 
    150:
    YKCFYRETDL | ASVIYVYVQD | YRSPFIASVS | DQHGVVYITE | NKNKTVVIPC | 
    200:
    LGSISNLNVS | LCARYPEKRF | VPDGNRISWD | SKKGFTIPSY | MISYAGMVFC | 
    250:
    EAKINDESYQ | SIMYIVVVVG | YRIYDVVLSP | SHGIELSVGE | KLVLNCTART | 
    300:
    ELNVGIDFNW | EYPSSKHQHK | KLVNRDLKTQ | SGSEMKKFLS | TLTIDGVTRS | 
    350:
    DQGLYTCAAS | SGLMTKKNST | FVRVHEKPFV | AFGSGMESLV | EATVGERVRI | 
    400:
    PAKYLGYPPP | EIKWYKNGIP | LESNHTIKAG | HVLTIMEVSE | RDTGNYTVIL | 
    450:
    TNPISKEKQS | HVVSLVVYVP | PQIGEKSLIS | PVDSYQYGTT | QTLTCTVYAI | 
    500:
    PPPHHIHWYW | QLEEECANEP | SQAVSVTNPY | PCEEWRSVED | FQGGNKIEVN | 
    550:
    KNQFALIEGK | NKTVSTLVIQ | AANVSALYKC | EAVNKVGRGE | RVISFHVTRG | 
    600:
    PEITLQPDMQ | PTEQESVSLW | CTADRSTFEN | LTWYKLGPQP | LPIHVGELPT | 
    650:
    PVCKNLDTLW | KLNATMFSNS | TNDILIMELK | NASLQDQGDY | VCLAQDRKTK | 
    700:
    KRHCVVRQLT | VLERVAPTIT | GNLENQTTSI | GESIEVSCTA | SGNPPPQIMW | 
    750:
    FKDNETLVED | SGIVLKDGNR | NLTIRRVRKE | DEGLYTCQAC | SVLGCAKVEA | 
    800:
    FFIIEGAQEK | TNLEIIILVG | TAVIAMFFWL | LLVIILRTVK | RANGGELKTG | 
    850:
    YLSIVMDPDE | LPLDEHCERL | PYDASKWEFP | RDRLKLGKPL | GRGAFGQVIE | 
    900:
    ADAFGIDKTA | TCRTVAVKML | KEGATHSEHR | ALMSELKILI | HIGHHLNVVN | 
    950:
    LLGACTKPGG | PLMVIVEFCK | FGNLSTYLRS | KRNEFVPYKT | KGARFRQGKD | 
    1000:
    YVGAIPVDLK | RRLDSITSSQ | SSASSGFVEE | KSLSDVEEEE | APEDLYKDFL | 
    1050:
    TLEHLICYSF | QVAKGMEFLA | SRKCIHRDLA | ARNILLSEKN | VVKICDFGLA | 
    1100:
    RDIYKDPDYV | RKGDARLPLK | WMAPETIFDR | VYTIQSDVWS | FGVLLWEIFS | 
    1150:
    LGASPYPGVK | IDEEFCRRLK | EGTRMRAPDY | TTPEMYQTML | DCWHGEPSQR | 
    1200:
    PTFSELVEHL | GNLLQANAQQ | DGKDYIVLPI | SETLSMEEDS | GLSLPTSPVS | 
    1250:
    CMEEEEVCDP | KFHYDNTAGI | SQYLQNSKRK | SRPVSVKTFE | DIPLEEPEVK | 
    1300:
    VIPDDNQTDS | GMVLASEELK | TLEDRTKLSP | SFGGMVPSKS | RESVASEGSN | 
    1350:
    QTSGYQSGYH | SDDTDTTVYS | SEEAELLKLI | EIGVQTGSTA | QILQPDSGTT | 
    1356:
    LSSPPV
    3D Structure:
    N/A
    Predicted Eptitope:
    Please Sign in.
    EIAab Sequence  Vaild Sequence:
    Please Sign in.
    Related Databases
    String:
    KEGG:
    MIM:
    Pfam:
    SMR:
    UniGene:
    Uniprot:
     
    FOR
    ELISA Kit for Human VEGFR-2
    Cat.:
    E0148h
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    Range:
    Please sign in first.
    ELISA Kit for Human VEGFR-2
    Cat.:
    E0148r
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    Range:
    Please sign in first.
    ELISA Kit for Human VEGFR-2
    Cat.:
    E0148m
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    Range:
    Please sign in first.
    CLIA Kit for Human VEGFR-2
    Cat.:
    U0148m
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    Range:
    Please sign in first.
    CLIA Kit for Human VEGFR-2
    Cat.:
    U0148r
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    Range:
    Please sign in first.
    CLIA Kit for Human VEGFR-2
    Cat.:
    U0148h
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    Polyclonal Antibody for Human VEGFR-2
    Cat.:
    P0148Rb-h
    Price:
    Please sign in first.
    Packing:
    40ug/0.2ml
    Polyclonal Antibody for Human VEGFR-2
    Cat.:
    P0148Rb-r
    Price:
    Please sign in first.
    Packing:
    40ug/0.2ml
    Polyclonal Antibody for Human VEGFR-2
    Cat.:
    P0148Rb-m
    Price:
    Please sign in first.
    Packing:
    40ug/0.2ml
    Monoclonal Antibody for Human VEGFR-2
    Monoclonal Antibody for Human VEGFR-2
    Monoclonal Antibody for Human VEGFR-2
    Protein for Human VEGFR-2
    Protein for Human VEGFR-2
    Protein for Human VEGFR-2

    R&D Technical Data
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Precision
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Recovery
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Linearity
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    References
    1. 1.
      "Novel splice variants derived from the receptor tyrosine kinase superfamily are potential therapeutics for rheumatoid arthritis."
      Jin P. , Zhang J. , Sumariwalla P.F. , Ni I. , Jorgensen B. , Crawford D. , Phillips S. , Feldmann M. , Shepard H.M. , Paleolog E.M.
      Arthritis Res. Ther.10:R73-R73(2008) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3);INTERACTION WITH VEGFC;SUBCELLULAR LOCATION
    2. 2.
      "Alternatively spliced vascular endothelial growth factor receptor-2 is an essential endogenous inhibitor of lymphatic vessel growth."
      Albuquerque R.J. , Hayashi T. , Cho W.G. , Kleinman M.E. , Dridi S. , Takeda A. , Baffi J.Z. , Yamada K. , Kaneko H. , Green M.G. , Chappell J. , Wilting J. , Weich H.A. , Yamagami S. , Amano S. , Mizuki N. , Alexander J.S. , Peterson M.L. , more...
      Nat. Med.15:1023-1030(2009) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2);FUNCTION IN INHIBITION OF LYMPHANGIOGENESIS;INTERACTION WITH VEGFC;TISSUE SPECIFICITY
    3. 3.
      "Full length human KDR/flk-1 sequence."
      Yin L.Y. , Wu Y. , Patterson C.
      Submitted (1997-12) to the EMBL/GenBank/DDBJ databases
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)
    4. 4.
      "Coding region for human VEGF receptor KDR (VEGFR-2)."
      Yu Y. , Whitney R.G. , Sato J.D.
      Submitted (1998-05) to the EMBL/GenBank/DDBJ databases
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)
      tissue: Umbilical vein.
    5. 5.
      "Generation and annotation of the DNA sequences of human chromosomes 2 and 4."
      Hillier L.W. , Graves T.A. , Fulton R.S. , Fulton L.A. , Pepin K.H. , Minx P. , Wagner-McPherson C. , Layman D. , Wylie K. , Sekhon M. , Becker M.C. , Fewell G.A. , Delehaunty K.D. , Miner T.L. , Nash W.E. , Kremitzki C. , Oddy L. , Du H. , more...
      Nature434:724-731(2005) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]
    6. 6.
      "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
      The MGC Project Team
      Genome Res.14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1);VARIANT HIS-472
    7. 7.
      "Identification of a new endothelial cell growth factor receptor tyrosine kinase."
      Terman B.I. , Carrion M.E. , Kovacs E. , Rasmussen B.A. , Eddy R.L. , Shows T.B.
      Oncogene6:1677-1683(1991) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 3-1356 (ISOFORM 1);VARIANT GLU-848
      tissue: Umbilical vein.
    8. 8.
      "Cloning and functional analysis of the promoter for KDR/flk-1, a receptor for vascular endothelial growth factor."
      Patterson C. , Perrella M.A. , Hsieh C.-M. , Yoshizumi M. , Lee M.-E. , Harber E.
      J. Biol. Chem.270:23111-23118(1995) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-22
    9. 9.
      "Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor."
      Terman B.I. , Dougher-Vermazen M. , Carrion M.E. , Dimitrov D. , Armellino D.C. , Gospodarowicz D. , Boehlen P.
      Biochem. Biophys. Res. Commun.187:1579-1586(1992) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: FUNCTION;SUBCELLULAR LOCATION;INTERACTION WITH VEGFA
    10. 10.
      "Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor."
      Waltenberger J. , Claesson-Welsh L. , Siegbahn A. , Shibuya M. , Heldin C.H.
      J. Biol. Chem.269:26988-26995(1994) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: FUNCTION AS VEGFA RECEPTOR; IN REGULATION OF CELL SHAPE; ACTIN CYTOSKELETON REORGANIZATION; CELL MIGRATION AND CELL PROLIFERATION;AUTOPHOSPHORYLATION
    11. 11.
      "The 230 kDa mature form of KDR/Flk-1 (VEGF receptor-2) activates the PLC-gamma pathway and partially induces mitotic signals in NIH3T3 fibroblasts."
      Takahashi T. , Shibuya M.
      Oncogene14:2079-2089(1997) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: FUNCTION IN VEGFA SIGNALING; PHOSPHORYLATION OF PLCG1; ACTIVATION OF MAP KINASES AND IN PROMOTING PROLIFERATION OF ENDOTHELIAL CELLS;INTERACTION WITH VEGFA AND PLCG1;AUTOPHOSPHORYLATION;SUBCELLULAR LOCATION;GLYCOSYLATION
    12. 12.
      "VEGF-A induces expression of eNOS and iNOS in endothelial cells via VEGF receptor-2 (KDR)."
      Kroll J. , Waltenberger J.
      Biochem. Biophys. Res. Commun.252:743-746(1998) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: FUNCTION IN INDUCTION OF NOS2 AND NOS3
    13. 13.
      "Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation."
      Gerber H.P. , McMurtrey A. , Kowalski J. , Yan M. , Keyt B.A. , Dixit V. , Ferrara N.
      J. Biol. Chem.273:30336-30343(1998) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: FUNCTION IN ACTIVATION OF THE PHOSPHATIDYLINOSITOL 3-KINASE AND AKT1 SIGNALING PATHWAY
    14. 14.
      "A novel function of VEGF receptor-2 (KDR): rapid release of nitric oxide in response to VEGF-A stimulation in endothelial cells."
      Kroll J. , Waltenberger J.
      Biochem. Biophys. Res. Commun.265:636-639(1999) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: FUNCTION IN NITRIC OXIDE RELEASE
    15. 15.
      "Vascular endothelial growth factor receptor KDR tyrosine kinase activity is increased by autophosphorylation of two activation loop tyrosine residues."
      Kendall R.L. , Rutledge R.Z. , Mao X. , Tebben A.J. , Hungate R.W. , Thomas K.A.
      J. Biol. Chem.274:6453-6460(1999) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: CATALYTIC ACTIVITY;CHARACTERIZATION OF VARIANT GLU-848;PHOSPHORYLATION AT TYR-1054 AND TYR-1059;ENZYME REGULATION
    16. 16.
      "Autophosphorylation of KDR in the kinase domain is required for maximal VEGF-stimulated kinase activity and receptor internalization."
      Dougher M. , Terman B.I.
      Oncogene18:1619-1627(1999) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: FUNCTION IN PHOSPHORYLATION OF PLCG1 AND PTK2/FAK1;INTERACTION WITH VEGFA;CATALYTIC ACTIVITY;PHOSPHORYLATION AT TYR-996; TYR-1054 AND TYR-1059;MUTAGENESIS OF TYR-996; TYR-1054 AND TYR-1059;SUBCELLULAR LOCATION;ENZYME REGULATION
    17. 17.
      "Identification of specific molecular structures of human immunodeficiency virus type 1 Tat relevant for its biological effects on vascular endothelial cells."
      Mitola S. , Soldi R. , Zanon I. , Barra L. , Gutierrez M.I. , Berkhout B. , Giacca M. , Bussolino F.
      J. Virol.74:344-353(2000) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: INTERACTION WITH HIV-1 TAT
    18. 18.
      "A single autophosphorylation site on KDR/Flk-1 is essential for VEGF-A-dependent activation of PLC-gamma and DNA synthesis in vascular endothelial cells."
      Takahashi T. , Yamaguchi S. , Chida K. , Shibuya M.
      EMBO J.20:2768-2778(2001) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: FUNCTION IN ENDOTHELIAL CELL PROLIFERATION; PHOSPHORYLATION OF PLCG1 AND ACTIVATION OF MAP KINASES;PHOSPHORYLATION AT TYR-1175 AND TYR-1214;MUTAGENESIS OF LYS-868 AND TYR-1175
    19. 19.
      "Vascular endothelial growth factor-dependent down-regulation of Flk-1/KDR involves Cbl-mediated ubiquitination. Consequences on nitric oxide production from endothelial cells."
      Duval M. , Bedard-Goulet S. , Delisle C. , Gratton J.P.
      J. Biol. Chem.278:20091-20097(2003) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: UBIQUITINATION;FUNCTION IN NITRIC OXIDE PRODUCTION;SUBCELLULAR LOCATION;INTERACTION WITH CBL
    20. 20.
      "Ligand-induced vascular endothelial growth factor receptor-3 (VEGFR-3) heterodimerization with VEGFR-2 in primary lymphatic endothelial cells regulates tyrosine phosphorylation sites."
      Dixelius J. , Makinen T. , Wirzenius M. , Karkkainen M.J. , Wernstedt C. , Alitalo K. , Claesson-Welsh L.
      J. Biol. Chem.278:40973-40979(2003) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: INTERACTION WITH FLT4
    21. 21.
      "The adaptor protein shb binds to tyrosine 1175 in vascular endothelial growth factor (VEGF) receptor-2 and regulates VEGF-dependent cellular migration."
      Holmqvist K. , Cross M.J. , Rolny C. , Haegerkvist R. , Rahimi N. , Matsumoto T. , Claesson-Welsh L. , Welsh M.
      J. Biol. Chem.279:22267-22275(2004) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: INTERACTION WITH SHB;FUNCTION IN CELL MIGRATION
    22. 22.
      "Phosphorylated KDR is expressed in the neoplastic and stromal elements of human renal tumours and shuttles from cell membrane to nucleus."
      Fox S.B. , Turley H. , Cheale M. , Blazquez C. , Roberts H. , James N. , Cook N. , Harris A. , Gatter K.
      J. Pathol.202:313-320(2004) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: SUBCELLULAR LOCATION;PHOSPHORYLATION
    23. 23.
      "Vascular endothelial growth factor (VEGF)-D and VEGF-A differentially regulate KDR-mediated signaling and biological function in vascular endothelial cells."
      Jia H. , Bagherzadeh A. , Bicknell R. , Duchen M.R. , Liu D. , Zachary I.
      J. Biol. Chem.279:36148-36157(2004) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: INTERACTION WITH VEGFA AND VEGFD;PHOSPHORYLATION AT TYR-1054 AND TYR-1059;FUNCTION IN VEGFA AND VEGFD SIGNALING; ACTIVATION OF MAPK1/ERK2 AND MAPK3/ERK1; ACTIVATION OF AKT1; PHOSPHORYLATION OF PLCG1 AND NOS3; MODULATION OF INTRACELLULAR CA(2+) LEVELS; CELL SURVIVAL AND POSITIVE REGULATION OF CELL PROLIFERATION; CELL MIGRATION AND ANGIOGENESIS;ENZYME REGULATION
    24. 24.
      "VEGF receptor-2 Y951 signaling and a role for the adapter molecule TSAd in tumor angiogenesis."
      Matsumoto T. , Bohman S. , Dixelius J. , Berge T. , Dimberg A. , Magnusson P. , Wang L. , Wikner C. , Qi J.H. , Wernstedt C. , Wu J. , Bruheim S. , Mugishima H. , Mukhopadhyay D. , Spurkland A. , Claesson-Welsh L.
      EMBO J.24:2342-2353(2005) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: FUNCTION IN CELL MIGRATION; PHOSPHORYLATION OF PLCG1; ACTIVATION OF MAPK1/ERK2; MAPK3/ERK1 AND THE MAP KINASES AND IN REGULATION OF ACTIN CYTOSKELETON REORGANIZATION;INTERACTION WITH SH2D2A/TSAD;PHOSPHORYLATION AT TYR-951; TYR-1054; TYR-1059; TYR-1214; TYR-1305; TYR-1309 AND TYR-1319;MUTAGENESIS OF TYR-951
    25. 25.
      "Phosphorylation of Tyr1214 within VEGFR-2 triggers the recruitment of Nck and activation of Fyn leading to SAPK2/p38 activation and endothelial cell migration in response to VEGF."
      Lamalice L. , Houle F. , Huot J.
      J. Biol. Chem.281:34009-34020(2006) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: FUNCTION IN ENDOTHELIAL CELL MIGRATION; ACTIVATION OF MAP KINASES AND IN PHOSPHORYLATION OF FYN; SRC AND NCK1;INTERACTION WITH GRB2; FYN AND NCK1;MUTAGENESIS OF TYR-1214
    26. 26.
      "Intrinsic tyrosine kinase activity is required for vascular endothelial growth factor receptor 2 ubiquitination, sorting and degradation in endothelial cells."
      Ewan L.C. , Jopling H.M. , Jia H. , Mittar S. , Bagherzadeh A. , Howell G.J. , Walker J.H. , Zachary I.C. , Ponnambalam S.
      Traffic7:1270-1282(2006) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: SUBCELLULAR LOCATION;UBIQUITINATION;DEGRADATION
    27. 27.
      "Phosphorylation of tyrosine 801 of vascular endothelial growth factor receptor-2 is necessary for Akt-dependent endothelial nitric-oxide synthase activation and nitric oxide release from endothelial cells."
      Blanes M.G. , Oubaha M. , Rautureau Y. , Gratton J.P.
      J. Biol. Chem.282:10660-10669(2007) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: FUNCTION IN ACTIVATION OF AKT1; PHOSPHORYLATION OF PLCG1 AND NOS3 AND REGULATION OF NITRIC OXIDE PRODUCTION;PHOSPHORYLATION AT TYR-801;MUTAGENESIS OF TYR-801
    28. 28.
      "AIP1 functions as an endogenous inhibitor of VEGFR2-mediated signaling and inflammatory angiogenesis in mice."
      Zhang H. , He Y. , Dai S. , Xu Z. , Luo Y. , Wan T. , Luo D. , Jones D. , Tang S. , Chen H. , Sessa W.C. , Min W.
      J. Clin. Invest.118:3904-3916(2008) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: INTERACTION WITH DAB2IP
    29. 29.
      "Transcriptional profiling reveals a critical role for tyrosine phosphatase VE-PTP in regulation of VEGFR2 activity and endothelial cell morphogenesis."
      Mellberg S. , Dimberg A. , Bahram F. , Hayashi M. , Rennel E. , Ameur A. , Westholm J.O. , Larsson E. , Lindahl P. , Cross M.J. , Claesson-Welsh L.
      FASEB J.23:1490-1502(2009) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: PHOSPHORYLATION AT TYR-951; TYR-1175 AND TYR-1214;DEPHOSPHORYLATION BY PTPRB
    30. 30.
      "New role for the protein tyrosine phosphatase DEP-1 in Akt activation and endothelial cell survival."
      Chabot C. , Spring K. , Gratton J.P. , Elchebly M. , Royal I.
      Mol. Cell. Biol.29:241-253(2009) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: PHOSPHORYLATION AT TYR-801; TYR-951; TYR-996; TYR-1054; TYR-1059; TYR-1175 AND TYR-1214; DEPHOSPHORYLATION AT TYR-951; TYR-996; TYR-1054; TYR-1059; TYR-1175 AND TYR-1214 BY PTPRJ
    31. 31.
      "VEGF-dependent tumor angiogenesis requires inverse and reciprocal regulation of VEGFR1 and VEGFR2."
      Zhang Z. , Neiva K.G. , Lingen M.W. , Ellis L.M. , Nor J.E.
      Cell Death Differ.17:499-512(2010) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: FUNCTION AS VEGFA RECEPTOR IN TUMOR ANGIOGENESIS;SUBCELLULAR LOCATION;UBIQUITINATION
    32. 32.
      "Neuroblastoma progression correlates with downregulation of the lymphangiogenesis inhibitor sVEGFR-2."
      Becker J. , Pavlakovic H. , Ludewig F. , Wilting F. , Weich H.A. , Albuquerque R. , Ambati J. , Wilting J.
      Clin. Cancer Res.16:1431-1441(2010) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: FUNCTION IN LYMPHANGIOGENESIS (ISOFORM 2)
    33. 33.
      "VEGF receptor 2/-3 heterodimers detected in situ by proximity ligation on angiogenic sprouts."
      Nilsson I. , Bahram F. , Li X. , Gualandi L. , Koch S. , Jarvius M. , Soderberg O. , Anisimov A. , Kholova I. , Pytowski B. , Baldwin M. , Yla-Herttuala S. , Alitalo K. , Kreuger J. , Claesson-Welsh L.
      EMBO J.29:1377-1388(2010) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: INTERACTION WITH VEGFC AND FLT4;SUBCELLULAR LOCATION;FUNCTION IN ANGIOGENESIS
    34. 34.
      "The VEGFR2 receptor tyrosine kinase undergoes constitutive endosome-to-plasma membrane recycling."
      Jopling H.M. , Howell G.J. , Gamper N. , Ponnambalam S.
      Biochem. Biophys. Res. Commun.410:170-176(2011) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: SUBCELLULAR LOCATION
    35. 35.
      "Blood vessel endothelial VEGFR-2 delays lymphangiogenesis: an endogenous trapping mechanism links lymph- and angiogenesis."
      Nakao S. , Zandi S. , Hata Y. , Kawahara S. , Arita R. , Schering A. , Sun D. , Melhorn M.I. , Ito Y. , Lara-Castillo N. , Ishibashi T. , Hafezi-Moghadam A.
      Blood117:1081-1090(2011) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: FUNCTION IN LYMPHANGIOGENESIS;INTERACTION WITH FLT4 AND VEGFC
    36. 36.
      "Differential roles of vascular endothelial growth factor receptor-1 and receptor-2 in angiogenesis."
      Shibuya M.
      J. Biochem. Mol. Biol.39:469-478(2006) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: REVIEW ON ROLE IN ANGIOGENESIS
    37. 37.
      "Vascular endothelial growth factor receptor-2: structure, function, intracellular signalling and therapeutic inhibition."
      Holmes K. , Roberts O.L. , Thomas A.M. , Cross M.J.
      Cell. Signal.19:2003-2012(2007) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: REVIEW
    38. 38.
      "VEGF receptor protein-tyrosine kinases: structure and regulation."
      Roskoski R. Jr.
      Biochem. Biophys. Res. Commun.375:287-291(2008) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: REVIEW ON STRUCTURE AND FUNCTION
    39. 39.
      "VEGFs and receptors involved in angiogenesis versus lymphangiogenesis."
      Lohela M. , Bry M. , Tammela T. , Alitalo K.
      Curr. Opin. Cell Biol.21:154-165(2009) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: REVIEW ON ROLE IN ANGIOGENESIS AND CANCER
    40. 40.
      "Structure-function analysis of VEGF receptor activation and the role of coreceptors in angiogenic signaling."
      Grunewald F.S. , Prota A.E. , Giese A. , Ballmer-Hofer K.
      Biochim. Biophys. Acta1804:567-580(2010) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: REVIEW ON LIGAND SPECIFICITY; FUNCTION; STRUCTURE; PHOSPHORYLATION AND SIGNALING
    41. 41.
      "Vascular endothelial growth factor receptor-2 in breast cancer."
      Guo S. , Colbert L.S. , Fuller M. , Zhang Y. , Gonzalez-Perez R.R.
      Biochim. Biophys. Acta1806:108-121(2010) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: REVIEW ON ROLE IN ANGIOGENESIS AND CANCER
    42. 42.
      "Tyrosine kinase receptor Flt/VEGFR family: its characterization related to angiogenesis and cancer."
      Shibuya M.
      Genes Cancer1:1119-1123(2010) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: REVIEW ON ROLE IN ANGIOGENESIS AND CANCER
    43. 43.
      "Signal transduction by vascular endothelial growth factor receptors."
      Koch S. , Tugues S. , Li X. , Gualandi L. , Claesson-Welsh L.
      Biochem. J.437:169-183(2011) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: REVIEW ON LIGAND SPECIFICITY; FUNCTION; STRUCTURE; PHOSPHORYLATION AND SIGNALING
    44. 44.
      "System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation."
      Rigbolt K.T. , Prokhorova T.A. , Akimov V. , Henningsen J. , Johansen P.T. , Kratchmarova I. , Kassem M. , Mann M. , Olsen J.V. , Blagoev B.
      Sci. Signal.4:RS3-RS3(2011) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-982 AND SER-984;IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
    45. 45.
      "Programmed cell death 6 (PDCD6) inhibits angiogenesis through PI3K/mTOR/p70S6K pathway by interacting of VEGFR-2."
      Rho S.B. , Song Y.J. , Lim M.C. , Lee S.H. , Kim B.R. , Park S.Y.
      Cell. Signal.24:131-139(2012) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: FUNCTION;INTERACTION WITH PDCD6
    46. 46.
      "VEGFR2 functions as an H(2)S-targeting receptor protein kinase with its novel Cys1045-Cys1024 disulfide bond serving as a specific molecular switch for hydrogen sulfide actions in vascular endothelial cells."
      Tao B.B. , Liu S.Y. , Zhang C.C. , Fu W. , Cai W.J. , Wang Y. , Shen Q. , Wang M.J. , Chen Y. , Zhang L.J. , Zhu Y.Z. , Zhu Y.C.
      Antioxid. Redox Signal.19:448-464(2013) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: ENZYME REGULATION;REDOX-ACTIVE DISULFIDE BOND;MUTAGENESIS OF CYS-1045
    47. 47.
      "Crystal structure of the kinase domain of human vascular endothelial growth factor receptor 2: a key enzyme in angiogenesis."
      McTigue M.A. , Wickersham J.A. , Pinko C. , Showalter R.E. , Parast C.V. , Tempczyk-Russell A. , Gehring M.R. , Mroczkowski B. , Kan C.-C. , Villafranca J.E. , Appelt K.
      Structure7:319-330(1999) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 806-1171;FUNCTION;PHOSPHORYLATION AT TYR-1059;IDENTIFICATION BY MASS SPECTROMETRY
    48. 48.
      "Novel 4-amino-furo[2,3-d]pyrimidines as Tie-2 and VEGFR2 dual inhibitors."
      Miyazaki Y. , Matsunaga S. , Tang J. , Maeda Y. , Nakano M. , Philippe R.J. , Shibahara M. , Liu W. , Sato H. , Wang L. , Nolte R.T.
      Bioorg. Med. Chem. Lett.15:2203-2207(2005) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: X-RAY CRYSTALLOGRAPHY (1.71 ANGSTROMS) OF 806-1171 IN COMPLEX WITH SYNTHETIC INHIBITOR
    49. 49.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: X-RAY CRYSTALLOGRAPHY (1.95 ANGSTROMS) OF 815-1171 IN COMPLEX WITH SYNTHETIC INHIBITOR
    50. 50.
      "Design, synthesis, and biological evaluation of novel 3-aryl-4-(1H-indole-3yl)-1,5-dihydro-2H-pyrrole-2-ones as vascular endothelial growth factor receptor (VEGF-R) inhibitors."
      Peifer C. , Selig R. , Kinkel K. , Ott D. , Totzke F. , Schaechtele C. , Heidenreich R. , Roecken M. , Schollmeyer D. , Laufer S.
      J. Med. Chem.51:3814-3824(2008) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 806-1171 IN COMPLEX WITH SYNTHETIC INHIBITOR;FUNCTION
    51. 51.
      "Direct contacts between extracellular membrane-proximal domains are required for VEGF receptor activation and cell signaling."
      Yang Y. , Xie P. , Opatowsky Y. , Schlessinger J.
      Proc. Natl. Acad. Sci. U.S.A.107:1906-1911(2010) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: X-RAY CRYSTALLOGRAPHY (2.70 ANGSTROMS) OF 657-764;SUBUNIT;AUTOPHOSPHORYLATION;FUNCTION IN VEGFA SIGNALING AND ACTIVATION OF MAPK1/ERK2 AND MAPK3/ERK1;MUTAGENESIS OF ARG-726 AND ASP-731
    52. 52.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: X-RAY CRYSTALLOGRAPHY (2.70 ANGSTROMS) OF 120-326 IN COMPLEX WITH VEGFC;INTERACTION WITH VEGFC;DOMAIN;DISULFIDE BONDS;GLYCOSYLATION AT ASN-143; ASN-245 AND ASN-318
    53. 53.
      "The structural basis for the function of two anti-VEGF receptor 2 antibodies."
      Franklin M.C. , Navarro E.C. , Wang Y. , Patel S. , Singh P. , Zhang Y. , Persaud K. , Bari A. , Griffith H. , Shen L. , Balderes P. , Kussie P.
      Structure19:1097-1107(2011) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 220-338 IN COMPLEX WITH ANTIBODY FRAGMENT;DISULFIDE BOND;GLYCOSYLATION AT ASN-245 AND ASN-318
    54. 54.
      "Somatic mutation of vascular endothelial growth factor receptors in juvenile hemangioma."
      Walter J.W. , North P.E. , Waner M. , Mizeracki A. , Blei F. , Walker J.W.T. , Reinisch J.F. , Marchuk D.A.
      Genes Chromosomes Cancer33:295-303(2002) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT HCI SER-1147
    55. 55.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS [LARGE SCALE ANALYSIS] LEU-275 AND ARG-873
    56. 56.
      "Patterns of somatic mutation in human cancer genomes."
      Greenman C. , Stephens P. , Smith R. , Dalgliesh G.L. , Hunter C. , Bignell G. , Davies H. , Teague J. , Butler A. , Stevens C. , Edkins S. , O'Meara S. , Vastrik I. , Schmidt E.E. , Avis T. , Barthorpe S. , Bhamra G. , Buck G. , more...
      Nature446:153-158(2007) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS [LARGE SCALE ANALYSIS] ARG-2; MET-136; GLY-248; ILE-297; VAL-462; HIS-472; ARG-482; ARG-539; MET-689; ASN-814 AND THR-1065
    57. 57.
      "Suppressed NFAT-dependent VEGFR1 expression and constitutive VEGFR2 signaling in infantile hemangioma."
      Jinnin M. , Medici D. , Park L. , Limaye N. , Liu Y. , Boscolo E. , Bischoff J. , Vikkula M. , Boye E. , Olsen B.R.
      Nat. Med.14:1236-1246(2008) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT HCI SUSCEPTIBILITY ARG-482
    Product Feedback Wall
    Hot Genes
    Top Searches
    Why choose EIAAB
    Our products have been quoted by many publications in famous journals such as Cell; Cell Metabolism; Hepatology; Biomaterials.more
    Further Information
    About us Protein center Bank account Distributors Terms & Conditions Career eiaab.com.cn

    Copyright & copy www.eiaab.com2006-2016 All Rights Reserved    EIAab         Email:eiaab@eiaab.com

    鄂ICP备10015095号-1

    鄂公网安备 42018502005535号

    Twitter